Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mika Saarela"'
Autor:
Anni Honkimaa, Joni Suppula, Olli Tynninen, Mika Saarela, Hanna Liimatainen, Pia Laine, Petri Auvinen, Eeva Auvinen
Publikováno v:
The Journal of Infectious Diseases.
Progressive multifocal leukoencephalopathy (PML) is a severe neurological condition caused by reactivation of JC polyomavirus (JCPyV) in immunosuppression. Asymptomatic JCPyV persists in peripheral tissues. Upon reactivation, neurotropic rearrangemen
Autor:
Martin Stangel, K. George, Inna Rubanovits, A. Kutschenko, Michael Schroeter, Juliane Klehmet, Tsugio Akutsu, Robert D. Henderson, S. Mumfrey, Takuya Ohkubo, Helmar C. Lehmann, Mari Auranen, Paul Bassett, Giuseppe Lauria, A. Di Muzio, Kenichi Kaida, David Yarnitsky, S. Larue, R. Gold, Fabian Klostermann, Karissa L. Gable, Ivo N. van Schaik, Gens Sobue, A Schenone, U. Sorro, Jeffrey A. Allen, S. Attarian, A. Algom, U. Chyrchel-Paszkiewicz, J. Haas, Jens Ejbye Schmidt, I. N. van Schaik, Jasper M. Morrow, Ingemar S. J. Merkies, R. Carne, C. Marquez Infante, Michael P. Lunn, Khema Sharma, E. Chi Ho Lai, Billie L. Durn, Satoshi Kuwabara, D. Kramer, David Gosal, P. MacDonald, Janneke G. J. Hoeijmakers, Giovanni Antonini, Senda Ajroud-Driss, S. Muley, Takanori Yokota, Tim Hagenacker, Eroboghene E. Ubogu, M. Kawai, Maria Salvado, Jean Pouget, Mika Saarela, John T. Kissel, Alexander Shtilbans, K. Kanai, B. Murinson, Olaf Hoffmann, Claudia Sommer, Sandro Sorbi, P. Berlit, Norman Latov, Nora A. Visser, C. G. Faber, A. Wielanek, J. Demeestere, Ericka Simpson, Ginna Gonzalez, Konrad Rejdak, C. Casanovas Pons, Alessandro Testori, Orell Mielke, T. Kalous, Alexa Cleasby, Vera Bril, J. Sussova, D. Mueller, Katrin Gross-Paju, Dale J. Lange, Nicolette C. Notermans, Florian Then Bergh, R. Talab, Kazumasa Yokoyama, M. Zibetti, C. Trebst, Marina Grandis, Miriam Freimer, E. Delmon, David R. Cornblath, Masahiro Mori, H. Onoue, Richard J. Barohn, D. Liebetanz, M. Chatzopoulos, J. Oechtering, F. Ciccocioppo, T. Rao, P. Van Damme, A. Sabet, Takashi Kanda, J. Zschuentzsch, Hans-Peter Hartung, S. Benitez, D. Aufauvre, M. Bednar, M. Tomiyama, G. Le Masson, C. D'Amour, Richard A. Lewis, Anne D. Sperfeld, I. Melamed, Lisa D. Hobson-Webb, Stefan Blum, Dario Cocito, K. Nishiyama, Daniele Cazzato, F. Bethke, Toomas Toomsoo, Said R. Beydoun, Leslie Roberts, David Walk, Josep Gamez, Masahiro Iijima, A. Jaspert-Grehl, Israel V. Drory, P. Kunc, John-Philip Lawo, C. Goerlitz, H. Johl, R. Yoon, Daniela M. Menichella, T. Lavin, Stefania Morino, K. Ohyama, Masayuki Baba, M. Antonia, Shafeeq Ladha, Claude Desnuelle, Pierre Clavelou, Andreas Meisel, Martin Vališ, Filip Eftimov, P. Baum, Sabrina Matà, Russell L. Chin, Mazen M. Dimachkie
Publikováno v:
Journal of the peripheral nervous system, 25(3), 230-237. Wiley-Blackwell
Journal of the Peripheral Nervous System
Journal of the Peripheral Nervous System
The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43063fcd25f2793a6b2337f883a18156
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
https://pure.amc.nl/en/publications/placebo-effect-in-chronic-inflammatory-demyelinating-polyneuropathy-the-path-study-and-a-systematic-review(82ad0dca-304a-4f5e-9f95-296f8e71a555).html
Autor:
Jean-Marc Léger, Ingemar S. J. Merkies, John-Philip Lawo, Björn Tackenberg, Jonathan M. Edelman, Mika Saarela, Claudia Sommer, Orell Mielke, Zbigniew Stelmasiak, Jan De Bleecker, Wim Robberecht, Jerzy Kamienowski
Publikováno v:
Journal of the Peripheral Nervous System. 22:149-152
Autor:
Joanne L. Jones, Alasdair Coles, Pentti J. Tienari, Mika Saarela, Keerthi Senthil, Merja Soilu-Hänninen, Laura Airas, Jukka T. Saarinen
Publikováno v:
Neurology. 90:849-851
Alemtuzumab is a highly effective treatment of relapsing-remitting multiple sclerosis (RRMS) with a complex safety profile, including secondary autoimmunity in 40% of patients [1]. We report two cases of hemophagocytic lymphohistiocytosis (HLH) in pa
Autor:
Michael Schroeter, Amgad Shebl, Leslie Roberts, Takuya Ohkubo, M. Chatzopoulos, Nan van Geloven, Robert D. Henderson, Catharina G. Faber, R. Talab, K. George, A. Kutschenko, E. Chi-Ho Lai, M. Bednar, Inna Rubanovits, Claudia Sommer, J. Oechtering, M. Tomiyama, Hans-Peter Hartung, Mari Auranen, G. Le Masson, Konrad Rejdak, Marina Grandis, Eroboghene E. Ubogu, Senda Ajroud-Driss, Tim Hagenacker, Lisa D. Hobson-Webb, Masayuki Baba, Khema Sharma, Miriam Freimer, Kazumasa Yokoyama, U. Chyrchel-Paszkiewicz, Karissa L. Gable, P. Van Damme, J. Zschuentzsch, I. N. van Schaik, S. Benitez, K. Nishiyama, J. Demeestere, Daniele Cazzato, F. Bethke, R. Carne, Gen Sobue, C. Marquez Infante, Norman Latov, David Walk, B. Murinson, Katrin Gross-Paju, Helmar C. Lehmann, M. Antonia, Ginna Gonzalez, M. Zibetti, Anne-Cécile Wielanek-Bachelet, Vera Bril, Stefania Morino, Mika Saarela, S. Mumfrey, Said R. Beydoun, Takanori Yokota, Maria Salvado, John T. Kissel, C. D'Amour, Ericka Simpson, D. Aufauvre, P. MacDonald, Orell Mielke, David R. Cornblath, Masahiro Iijima, Janneke G. J. Hoeijmakers, Nora A. Visser, Takashi Kanda, K. Kanai, Jeffrey A. Allen, Richard A. Lewis, Anne D. Sperfeld, J. Sussova, D. Mueller, A. Algom, Fabian Klostermann, I. Melamed, David Yarnitsky, J. Haas, Josep Gamez, A Schenone, P. Kunc, Ingemar S. J. Merkies, C. Trebst, F. Ciccocioppo, Ralf Gold, Vivian E. Drory, H. Onoue, Stefan Blum, P. Berlit, S. Muley, Tsugio Akutsu, T. Kalous, Michael P. Lunn, Alessandro Testori, Dale J. Lange, Giuseppe Lauria, D. Liebetanz, A. Jaspert-Grehl, Giovanni Antonini, Masahiro Mori, S. Larue, John-Philip Lawo, C. Goerlitz, H. Johl, M. Kawai, Nicolette C. Notermans, U. Sorro, R. Yoon, Daniela M. Menichella, T. Lavin, Billie L. Durn, J. Morrow, Richard J. Barohn, Dario Cocito, T. Rao, Martin Stangel, Satoshi Kuwabara, Jean Pouget, Emilien Delmont, David Gosal, Alexander Shtilbans, Sandro Sorbi, Florian Then Bergh, J. Schmidt, Shahram Attarian, Pierre Clavelou, Andreas Meisel, Sabrina Matà, Russell L. Chin, Mazen M. Dimachkie, Juliane Klehmet, K. Ohyama, Martin Vališ, Filip Eftimov, Shafeeq Ladha, A. Sabet, P. Baum, Claude Desnuelle, Kenichi Kaida, D. Kramer, Olaf Hoffmann, C. Casanovas Pons, A. Di Muzio, Ivo N. van Schaik, Toomas Toomsoo
Publikováno v:
Journal of the peripheral nervous system, 24(1), 72-79. Wiley-Blackwell
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of the Peripheral Nervous System, 24(1), 72. Wiley-Blackwell
Journal of the Peripheral Nervous System
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of the Peripheral Nervous System, 24(1), 72. Wiley-Blackwell
Journal of the Peripheral Nervous System
PATH study group.
In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the e
In patients with chronic inflammatory demyelinating polyneuropathy (CIDP), intravenous immunoglobulin (IVIG) is recommended to be periodically reduced to assess the need for ongoing therapy. However, little is known about the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7039eb5a61ad1011b5914f9a690d3c9c
https://pure.amc.nl/en/publications/restabilization-treatment-after-intravenous-immunoglobulin-withdrawal-in-chronic-inflammatory-demyelinating-polyneuropathy-results-from-the-prerandomization-phase-of-the-polyneuropathy-and-treatment-with-hizentra-study(a3597aa6-7290-41d2-9849-99a91b4daf0e).html
https://pure.amc.nl/en/publications/restabilization-treatment-after-intravenous-immunoglobulin-withdrawal-in-chronic-inflammatory-demyelinating-polyneuropathy-results-from-the-prerandomization-phase-of-the-polyneuropathy-and-treatment-with-hizentra-study(a3597aa6-7290-41d2-9849-99a91b4daf0e).html
Autor:
Ivo N van Schaik, Orell Mielke, Arman Sabet, Koshy George, Leslie Roberts, Ross Carne, Stefan Blum, Robert Henderson, Philip Van Damme, Jelle Demeestere, Sandrine Larue, Catherine-Andree Pinard D'Amour, Vera Bril, Ari Breiner, Pavel Kunc, Martin Valis, Jana Sussova, Tomas Kalous, Radomir Talab, Michal Bednar, Toomas Toomsoo, Inna Rubanovits, Katrin Gross-Paju, Ulvi Sorro, Mika Saarela, Mari Auranen, Jean Pouget, Shahram Attarian, Gwendal Le Masson, Anne-Cécile Wielanek-Bachelet, Claude Desnuelle, Emilien Delmont, Pierre Clavelou, Dominique Aufauvre, Jens Schmidt, Jana Zschuentssch, Claudia Sommer, Daniela Kramer, Olaf Hoffmann, Carsten Goerlitz, Judith Haas, Marko Chatzopoulos, Min-Suk Yoon, Ralf Gold, Peter Berlit, Andrea Jaspert-Grehl, David Liebetanz, Anna Kutschenko, Martin Stangel, Corinna Trebst, Petra Baum, Florian Then Bergh, Juliane Klehmet, Andreas Meisel, Fabian Klostermann, Johanna Oechtering, Helmar Lehmann, Michael Schroeter, Tim Hagenacker, Daniel Mueller, Anne-Dorte Sperfeld, Florian Bethke, Hans-Peter Hartung, Vivian Drory, Avi Algom, David Yarnitsky, Beth Brianna Murinson, Antonio Di Muzio, Fausta Ciccocioppo, Sandro Sorbi, Sabrina Mata, Angelo Schenone, Marina Grandis, Giuseppe Lauria, Daniele Cazzato, Giovanni Antonini, Stefania Morino, Dario Cocito, Maurizio Zibetti, Takanori Yokota, Takuya Ohkubo, Takashi Kanda, Motoharu Kawai, Kenichi Kaida, Hiroyuki Onoue, Satoshi Kuwabara, Masahiro Mori, Masahiro Iijima, Ken Ohyama, Gen Sobue, Masayuki Baba, Masahiko Tomiyama, Kazutoshi Nishiyama, Tsugio Akutsu, Kazumasa Yokoyama, Kazuaki Kanai, Ivo N. van Schaik, Filip Eftimov, Nicolette. C. Notermans, Nora. A. Visser, Catharina Faber, Janneke. G.J. Hoeijmakers, Ingemar S.J. Merkies, Nan van Geloven, Konrad Rejdak, Urszula Chyrchel-Paszkiewicz, Carlos Casanovas Pons, María Antonia Alberti Aguiló, Josep Gamez, María Figueras, Celedonio Marquez Infante, Sonia Benitez Rivero, Michael Lunn, Jasper Morrow, David Gosal, Timothy Myles Lavin, Isaac Melamed, Alessandro Testori, Senda Ajroud-Driss, Daniela Menichella, Ericka Simpson, Eugene Chi-Ho Lai, Mazen Dimachkie, Richard J. Barohn, Said Beydoun, Harpreet Johl, Dale Lange, Alexander Shtilbans, Suraj Muley, Shafeeq Ladha, Miriam Freimer, John Kissel, Norman Latov, Russell Chin, Eroboghene Ubogu, Sandi Mumfrey, T. Hermanth P. Rao, Paul MacDonald, Khema Sharma, Ginna Gonzalez, Jeffrey Allen, David Walk, Lisa Hobson-Webb, Karissa Gable, Richard A. Lewis, David R. Cornblath, John-Phillip Lawo, Michaela Praus, Billie L. Durn
Publikováno v:
Lancet neurology, 17(5), 393-394. Lancet Publishing Group
We thank Ravi Uniyal and colleagues for their comments on our results from the PATH trial1 on subcutaneous immunoglobulin (SCIg) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP). They express concern about the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5bbab476f42fdc4ef954363ef718221
http://hdl.handle.net/11567/941843
http://hdl.handle.net/11567/941843
Autor:
Sari, Atula, Kathrin, Pfau, Tapani, Salmi, Eero, Sihvo, Mikko, Haapio, Mika, Saarela, Mari, Auranen
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 133(11)
Myasthenia gravis (MG) is the most common neuromuscular transmission disorder, causing weakness of skeletal muscles on exertion. The course of the disease is highly variable, symptoms and signs may change rapidly due to infection or pregnancy. MG is
Autor:
Gen Sobue, Jerzy Kamienowski, Orell Mielke, Richard A. Lewis, Björn Tackenberg, Arman Sabet, Wim Robberecht, Billie L. Durn, Nan van Gloven, Mika Saarela, Claudia Sommer, John-Philip Lawo, Ivo N. van Schaik, Jan De Bleecker, Vera Bril, David R. Cornblath, Zbigniew Stelmasiak, Jean-Marc Léger, Hans-Peter Hartung, I. S. J. Merkies
Publikováno v:
Journal of Neurology, Neurosurgery & Psychiatry. 89:A19.2-A19
IntroductionWe analysed the efficacy and safety of IVIG IgPro10 (CSL Behring) in two CIDP studies: PRIMA and PATH.MethodsPRIMA was a prospective, open-label, single-arm study in 28 CIDP patients (n=13 IVIG-pretreated; n=15 untreated) investigating ef
Publikováno v:
Archives of Gerontology and Geriatrics. 25:311-319
The prognostic significance of difficulties in mobility was evaluated using the database of the Helsinki and Vantaa (Finland) ageing studies, in which random persons of four birth cohorts (65, 75, 80 and 85 years, N=1331) were followed for 5 years. D
Autor:
Jean-Marc, Léger, Jan L, De Bleecker, Claudia, Sommer, Wim, Robberecht, Mika, Saarela, Jerzy, Kamienowski, Zbigniew, Stelmasiak, Orell, Mielke, Björn, Tackenberg, Amgad, Shebl, Artur, Bauhofer, Othmar, Zenker, Ingemar S J, Merkies, G, Zwolińska
Publikováno v:
Journal of the Peripheral Nervous System
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
This prospective, multicenter, single-arm, open-label Phase III study aimed to evaluate the efficacy and safety of Privigen(®) (10% liquid human intravenous immunoglobulin [IVIG], stabilized with L-proline) in patients with chronic inflammatory demy